ConductScience.org, home

Paper36978147

APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential.

Butler K and 1 other. J Hematol Oncol, 2023. Cited by 65 papers, by iCite.

Cite this record

ConductScience Library. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential. Papers, record 36978147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36978147

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential.
PubMed
Journal
J Hematol Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
5.28
iCite
Revised in PubMed
2023-12-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Butler KKelly
2Banday ARA Rouf

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Clinical RelevanceMajor topic
NeoplasmsMajor topic
Humans
Mutagenesis
Mutation
Peptides
Cytidine Deaminase
Tumor Microenvironment
APOBEC Deaminases

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
IntramuralNIH HHSUnited StatesPubMedPubMed
ZIABC012091NIHNIH RePORTER

Download CSV of grants

References207

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133849962Targeted Deep Sequencing of Bladder Tumors Reveals Novel Associations between Cancer Gene Mutations and Mutational Signatures with Major Risk Factors.Clin Cancer Res2021https://conductscience.org/library/papers/33849962PubMed
227321955Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.Cancer Cell2016https://conductscience.org/library/papers/27321955PubMed
325163501Biological function of activation-induced cytidine deaminase (AID).Biomed J2014https://conductscience.org/library/papers/25163501PubMed
426459911The eQTL-missense polymorphisms of APOBEC3H are associated with lung cancer risk in a Han Chinese population.Sci Rep2015https://conductscience.org/library/papers/26459911PubMed
520192759The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.Annu Rev Biochem2010https://conductscience.org/library/papers/20192759PubMed
633863885An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.Nat Commun2021https://conductscience.org/library/papers/33863885PubMed
726178819The virus-induced protein APOBEC3G inhibits anoikis by activation of Akt kinase in pancreatic cancer cells.Sci Rep2015https://conductscience.org/library/papers/26178819PubMed
815098018Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.Nat Struct Mol Biol2004https://conductscience.org/library/papers/15098018PubMed
927643540Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.Nat Genet2016https://conductscience.org/library/papers/27643540PubMed
1024728294Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.Nat Genet2014https://conductscience.org/library/papers/24728294PubMed
1125650088Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma.Leukemia2015https://conductscience.org/library/papers/25650088PubMed
1223852170An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.Nat Genet2013https://conductscience.org/library/papers/23852170PubMed
1332719516APOBEC3-dependent kataegis and TREX1-driven chromothripsis during telomere crisis.Nat Genet2020https://conductscience.org/library/papers/32719516PubMed
1425401976FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.Oncotarget2015https://conductscience.org/library/papers/25401976PubMed
1535768438The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.Nat Commun2022https://conductscience.org/library/papers/35768438PubMed
1616926856Mechanism of homologous recombination: mediators and helicases take on regulatory functions.Nat Rev Mol Cell Biol2006https://conductscience.org/library/papers/16926856PubMed
1733947663Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution.Cancer Discov2021https://conductscience.org/library/papers/33947663PubMed
1827581627Role of E542 and E545 missense mutations of PIK3CA in breast cancer: a comparative computational approach.J Biomol Struct Dyn2017https://conductscience.org/library/papers/27581627PubMed
1924910434APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.Cell Rep2014https://conductscience.org/library/papers/24910434PubMed
2035673559APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.Theranostics2022https://conductscience.org/library/papers/35673559PubMed

See all 207 referencesDownload CSV of references

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
42884106Pan-Cancer APOBEC Mutagenesis, Immune Microenvironment, and Clinical Outcome: A Comprehensive Multi-Omics Analysis of All Ten Family Members Across 9653 TCGA Tumors.Int J Mol Sci2026https://conductscience.org/library/papers/42884106PubMed
42853602Punctuated mutagenesis promotes multi-step evolutionary adaptation in human cancers.Elife2026https://conductscience.org/library/papers/42853602PubMed
42845502Structure of full-length APOBEC3B bound to EBV BORF2 reveals coordinated neutralization of a cancer-associated mutator.Res Sq2026https://conductscience.org/library/papers/42845502PubMed
42791387Unraveling the lexicon of complex mutational phenomena in human cancers.Nat Cancer2026https://conductscience.org/library/papers/42791387PubMed
42717521APOBEC3 activity and DNA polymerase-ε deficiency are associated with distinct IDH1 R132 hotspot mutations.Mol Oncol2026https://conductscience.org/library/papers/42717521PubMed
42582228Hallmarks of lung cancer driven by inhalable particulate matter: From cell-intrinsic oncogenic traits to microenvironment remodeling.Innovation (Camb)2026https://conductscience.org/library/papers/42582228PubMed
42562966Recurrent PIK3CA-E545K mutation promotes cervical cancer growth and invasion via AKT/mTOR signaling.Mol Genet Genomics2026https://conductscience.org/library/papers/42562966PubMed
42523379APOBEC3G expression marks a TMB-high, T cell-inflamed tumor state and is associated with response to immune checkpoint blockade in multiple cancer cohorts.bioRxiv2026https://conductscience.org/library/papers/42523379PubMed
42472831Tumor evolution: signaling pathways, molecular mechanisms and therapeutic targets.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42472831PubMed
42259884Comparative analysis of genomic profiles and clinical outcomes in cholangiocarcinoma and gallbladder cancer.Sci Rep2026https://conductscience.org/library/papers/42259884PubMed
42158468Integrative Genomic and Functional Analysis Reveals NF1 Loss as a Modifier of DNA Damage and Replication Stress Responses in Ovarian Cancer.Hum Mutat2026https://conductscience.org/library/papers/42158468PubMed
42113333Dynamic ecosystems of tumor drug resistance mechanisms: from molecular heterogeneity to systemic interventions.Apoptosis2026https://conductscience.org/library/papers/42113333PubMed
42059071KSHV Genome in Saliva, Whole Blood and Kaposi's Sarcoma Biopsy Specimens in Republic of Congo: Phylogenetic Analysis and an APOBEC3B Mutational Signature.J Med Virol2026https://conductscience.org/library/papers/42059071PubMed
42027431Comprehensive analysis of mutational signatures and corresponding driver genes in cervical cancer from Xinjiang.Biochem Biophys Rep2026https://conductscience.org/library/papers/42027431PubMed
41938780Host restriction factors and p17-Driven inflammaging in HIV-1: From molecular pathogenesis to functional cure.AIMS Microbiol2026https://conductscience.org/library/papers/41938780PubMed
41858889Interferon signaling gene expression, and DNA methylation interactions in Sjögren's disease via mendelian randomization.iScience2026https://conductscience.org/library/papers/41858889PubMed
41826799Competing subclones and fitness diversity shape tumor evolution across cancer types.Bioinformatics2026https://conductscience.org/library/papers/41826799PubMed
41756300Reprogramming tumor immunity through APOBEC3s-mediated mutagenesis: from genome instability to immune checkpoint interactions.Front Immunol2026https://conductscience.org/library/papers/41756300PubMed
41737841The evolving mpox threat (2022-2024): clade dynamics, immune evasion, and escalating global health challenges.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/41737841PubMed
41606303Five dominant amino acid substitution signatures shape tumour immunity.Mol Syst Biol2026https://conductscience.org/library/papers/41606303PubMed

See all 51 cited byDownload CSV of cited by

Genes62

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADGRG657211PubTator's text mininghttps://conductscience.org/library/genes/57211NCBI Gene
AGAP2116986PubTator's text mininghttps://conductscience.org/library/genes/116986NCBI Gene
AICDA57379PubTator's text mininghttps://conductscience.org/library/genes/57379NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
APOB338PubTator's text mininghttps://conductscience.org/library/genes/338NCBI Gene
APOBEC1339PubTator's text mininghttps://conductscience.org/library/genes/339NCBI Gene
APOBEC210930PubTator's text mininghttps://conductscience.org/library/genes/10930NCBI Gene
APOBEC3A200315PubTator's text mininghttps://conductscience.org/library/genes/200315NCBI Gene
APOBEC3B9582PubTator's text mininghttps://conductscience.org/library/genes/9582NCBI Gene
APOBEC3C27350PubTator's text mininghttps://conductscience.org/library/genes/27350NCBI Gene
APOBEC3F200316PubTator's text mininghttps://conductscience.org/library/genes/200316NCBI Gene
APOBEC3G60489PubTator's text mininghttps://conductscience.org/library/genes/60489NCBI Gene
APOBEC3H164668PubTator's text mininghttps://conductscience.org/library/genes/164668NCBI Gene
APOBEC4403314PubTator's text mininghttps://conductscience.org/library/genes/403314NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
ATP2B4493PubTator's text mininghttps://conductscience.org/library/genes/493NCBI Gene
ATR545PubTator's text mininghttps://conductscience.org/library/genes/545NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene

See all 62 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36978147

GET https://conductscience.org/api/papers/v1/36978147/references?page=2